Significance of nitric oxide for patients with asthma;Význam měření oxidu dusnatého u nemocných astmatem

Casopis Lekaru Ceskych

Volumn 143, Issue 6, 2004, Pages 381-384

  Čáp, Petr ^a  

^a Oddeleni Klin Imunol a Alergologie   (Czech Republic)

Author keywords

Asthma; Exhaled air; Nitric oxide

Indexed keywords

ANTIINFLAMMATORY AGENT; NITRIC OXIDE;

ASTHMA; CLINICAL PRACTICE; CLINICAL RESEARCH; DIAGNOSTIC VALUE; DRUG EFFICACY; EXPIRED AIR; INFLAMMATION; PATIENT MONITORING; REVIEW;

ASTHMA; BIOLOGICAL MARKERS; BREATH TESTS; HUMANS; INFLAMMATION; NITRIC OXIDE;

EID: 3042617666     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Alving, K., Weitzberg, E., Lundberg, J.: Increased amount of nitric oxide in exhaled air of asthmatics. Eur. Respir. J., 1993, 6, s. 1368-1370.
2. Artlich, A., Busch, T., Lewandovski, K. et al.: Childhood asthma:exhaled nitric oxide in relation to clinical symptoms. Eur. Respir. J., 1999, 13, s. 1396-1401.
3. American Thoracic Society Official Statement. Recommendation for a standardized procedure fot the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children. Am. J. Respir. Crit. Care Med., 1999, 160, s. 2104-2117.
4. Bisgaard, H., Loland, L., Oj, A.: NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast. Am. J. Respir. Crit. Care Med., 1999, 160, s. 1227-1231.
5. Bratton, D., Lanz, M. J., Miyjazawa, N. et al.: Exhaled nitric oxide before and after montelukast sodium therapy in school-age children with chronic asthma: a preliminary study. Pediatr. Pulmonol., 1999, 28, s. 402-407.
6. Čáp, P., Pehal, F., Petrů, V., Musil, J.: Kondenzát vydechovaného vzduchu a možnosti jeho vyšetření. Alergie, 2001, 4, s. 275-280.
7. Čáp, P., Pehal, F., Petrů, V. et al.: Vyšetření leukotrienů v kondenzátu vydechovaného vzduchu u nemocných s astmatem. (pilotní studie) Alergie, 2002, 1, s. 15-20.
8. Čáp, P., Pehal, F., Petrů, V.: Hodnocení NO ve vydechovaném vzduchu a dalších ukazatelů zánětu v jeho kondenzátu. Alergie, 2003, (Suppl. 1), s. 39-40.
9. Fulsgang, G., Vikré-Jorgensen, J., Agertof, L. et al.: Effect of salmeterol treatment on nitric oxide level in exhaled air and dose-response to terbutalin in children with mild asthma. Pediatr. Pulmonol., 1998, 25, s. 314-321.
10. Gustafsson, L. E., Lerone, A. M., Persson, M. G. et al.: Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem. Biopsys. Res. Commun., 1991, 181, s. 852-857.
11. Hitka, P.: Význam stanovovania peroxidu vodíka vo vydechovanom vzduchu pre hodnotenie oxidačného poškodenia pĺuc. Čas. Lék. čes., 2003, 142, s. 202-206.
12. Chatkin, J. M., Ansarin, K, Silkoff, P. E. et al.: Exhaled nitric oxide as a noninvasive assessment of chronic cough. Am. J. Respir. Crit. Care. Med., 1999, 159, s. 1810-1813.
13. Jones, S. L., Kittelson, J., Cowan, J. O. et al.: The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am. J. Respir. Crit. Care Med., 2001, 164, s. 738-743.
14. Kharitonov, S., Yates, D., Robbins, R. et al.: Increased nitric oxide in exhaled air of asthmatic patients. Lancet, 1994, 343, s. 133-135.
15. Kharitonov, S., Barnes, P.: Clinical aspects of exhaled nitric oxide. Eur. Respir. J., 2000, 16, s. 781-792.
16. Kharitonov, S., Yates, D., Barnes, P.: Inhaled glucocortisteroids decrease nitric oxide in exhaled air of asthmatic patients. Am. J. Respir. Crit. Care. Med., 1996, 153, s. 454-457.
17. Kharitonov, S. A., Yates, D. H., Robbins, R. A. et al.: Increased nitric oxide in exhaled air of asthmatic patients. Lancet, 1994, 343, s. 133-135.
18. Kharitonov, S., Alving, K. Barnes, P. J.: ERS Task Force Report. Exhaled and nasal nitric oxide measurements: recommendations. Eur. Respir. J., 1997, 10, s. 1683-1693.
19. Kuo, H., Liu, S., Barnes, P. J.: The effect of endogenous nitric oxide on neurogenic plasma exsudation in guinea pigs airways. Eur. J, Pharmacol., 1992, 221, s. 385-388.
20. Lanz, M., Leung, D., Mc Cormick, D. et al.: Comparison of exhaled nitric oxide, serum eosinophilic cationic protein, and soluble interleukin-2 receptor in exacerbation of pediatric asthma. Pediatric Pulmonol., 1997, 24, s. 305-311.
21. Moody, A., Fergusson, W., Wells, A. et al.: Increased nitric oxide production in the respiratory tract in asymptomatic Pacific Islanders: an association with skin prick test reactivity to house dust mite. Allergy Clin. Immunol., 2000, 105, s. 895-899.
22. Musil, J., Čáp, P.: Vyšetření kondenzátu vydechovaného vzduchu. Studia pneumologica et phtiseologica, 2002, 62 (Suppl. 1), s. 27.
23. Papi, A. Romagnoli, M., Baraldo, S. et al.: Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in COPD. Am. J. Respir. Crit. Care Med., 2000, 162, s. 1773-1777.
24. Payne, D. N., Adcock, I. M., Wilson, N. M. et al.: Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolon. Am. J. Respir. Crit. Care Med., 2001, 164, s. 1376-1381.
25. Payne, D. N., Wilson, N., James, A. et al.: Evidence of different subgroups of difficult asthma in children. Thorax, 2001, 56, s. 345-350.
26. Piancentini, G. L. Bodini, A. Costella, S. et al.: Exhaled nitric oxide and sputum eosinophil markers of inflammation in asthmatic children. Eur. Respir. J., 1999, 13, s. 1386-1390.
27. Silkoff, P., McClean, P., Spino, M. et al.: Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients. Chest, 2001, 119, s. 1322-1328.
28. Sippel, J. M., Holden, W. E., Tilles, S. A. et al.: Exhaled nitric oxide levels correlate with measures of disease control in asthma. J. Allergy Clin. Immunol., 2000, 106, s. 645-650.
29. Srbová, M., Wilhelm, J.: Markery obsažené ve vydechovaném vzduchu při plicních onemocnění ch. Čas. Lék. čes., 2003, 142, s. 140-143.
30. van der Toorn, L. M., Oberbeek, S. E., de Jongste, J. C. et al.: Airway inflammation is present during clinical remission of atopic asthma. Am. J. Respir. Crit. Care Med., 2001, 164, s. 2107-2113.
31. van Rensen, E. L., Straathof, K. C., Veselic, C. et al.: Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils and exhaled nitric oxide levels in patients with asthma, Thorax, 1999, 54, s. 403-408.